FDA approves 1st long-acting HIV drug combo, monthly shots

Southwest Life

FDA approves 1st long-acting HIV drug combo, monthly shots

This image, provided by drugmaker ViiV Healthcare, shows a rendering of the packaging and vials containing its new HIV treatment, Cabenuva, approved by the U.S. Food and Drug Administration on Thursday, Jan. 21, 2021. U.S. regulators have approved the first long-acting combo drug for HIV, monthly shots that can replace the daily pills that have been used for decades to control infection with the AIDS virus.

FDA approves 1st long-acting HIV drug combo, monthly shots

This image, provided by drugmaker ViiV Healthcare, shows a rendering of the packaging and vials containing its new HIV treatment, Cabenuva, approved by the U.S. Food and Drug Administration on Thursday, Jan. 21, 2021. U.S. regulators have approved the first long-acting combo drug for HIV, monthly shots that can replace the daily pills that have been used for decades to control infection with the AIDS virus.
Listen
Loading the English audio player...
Escuchar en Español:
Loading the Español audio player...